About Stephen Linderman
Stephen Linderman is a chief executive officer and director at Absco Therapeutics.
Stephen Linderman first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Stephen Linderman in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Stephen Linderman works with at each company, as listed on that company's latest Form D.
Absco Therapeutics, Inc. · Form D, Aug 27, 2025
CT
Carlo Giovanni Traverso
Director
AS
Avik Som
Director